Glassman Wealth Services »

Design Therapeutics shares owned by Glassman Wealth Services

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Glassman Wealth Services from 13F filings

Historical chart of Glassman Wealth Services investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Glassman Wealth Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Glassman Wealth Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $776 293 2.65
2023-09-30 $1.3k 565 2.36

More positions owned by Glassman Wealth Services

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
NVR (NVR)
Dimensional Etf Trust World Ex Us Core (DFAX)
Apple (AAPL)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Snap-on Incorporated (SNA)
Microsoft Corporation (MSFT)
Ishares Tr Rus 1000 Etf (IWB)
Tesla Motors (TSLA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Glassman Wealth Services

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
Citadel Advisors
Baker Bros. Advisors
Tang Capital Management
Almitas Capital
Goldman Sachs Group
Vanguard Group
BML Capital Management
Two Sigma Advisers
Jacobs Levy Equity Management
Two Sigma Investments
Millennium Management
Walleye Trading Advisors
Assenagon Asset Management

View all funds holding Design Therapeutics